Taken together, these data suggest that blocking NKCC1 activity has impact on TMZ-induced activation of the WNK1-SPAK/OSR1-NKCC1 signaling pathway in both GL26 and SB28 glioma cells. The gene discussed is WNK1; the disease is central nervous system cancer.